Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action

Advancements in diabetes technology such as continuous glucose monitoring (CGM), insulin pumps, and automated insulin delivery provide opportunities to improve glycemic control for youth with type 1 diabetes (T1D). However, diabetes technology use is lower in youth on public insurance, and this tech...

Full description

Saved in:
Bibliographic Details
Main Authors: Ming Yeh Lee, Molly L. Tanenbaum, David M. Maahs, Priya Prahalad
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2022/9911736
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849399835047755776
author Ming Yeh Lee
Molly L. Tanenbaum
David M. Maahs
Priya Prahalad
author_facet Ming Yeh Lee
Molly L. Tanenbaum
David M. Maahs
Priya Prahalad
author_sort Ming Yeh Lee
collection DOAJ
description Advancements in diabetes technology such as continuous glucose monitoring (CGM), insulin pumps, and automated insulin delivery provide opportunities to improve glycemic control for youth with type 1 diabetes (T1D). However, diabetes technology use is lower in youth on public insurance, and this technology use gap is widening in the US. There is a significant need to develop effective interventions and policies to promote equitable care. The dual purpose of this case series is as follows: (1) describe success stories of the CGM Time in Range Program (CGM TIPs), which removed barriers for initiating CGM and provided asynchronous remote glucose monitoring for youth on public insurance, and (2) advocate for improving CGM coverage by public insurance. We describe a series of six youths with T1D and public insurance who obtained and sustained use of CGM with assistance from the program. Three youths had improved engagement with the care team while on CGM and the remote monitoring protocol, and three youths were able to leverage sustained CGM wear to obtain insurance coverage for automated insulin delivery systems. CGM TIPs helped these youths achieve lower hemoglobin A1c and improved time in range (TIR). Despite the successes, expansion of CGM TIPs is limited by stringent barriers for CGM approval and difficult postapproval patient workflows to receive shipments. These cases highlight the potential for combining diabetes technology and asynchronous remote monitoring to support continued use and provide education to improve glycemic control for youth with T1D on public insurance and the need to reduce barriers for obtaining CGM coverage by public insurance.
format Article
id doaj-art-9cddc14bad3b4f28a6b91169404cf5ec
institution Kabale University
issn 2090-651X
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Case Reports in Endocrinology
spelling doaj-art-9cddc14bad3b4f28a6b91169404cf5ec2025-08-20T03:38:14ZengWileyCase Reports in Endocrinology2090-651X2022-01-01202210.1155/2022/9911736Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to ActionMing Yeh Lee0Molly L. Tanenbaum1David M. Maahs2Priya Prahalad3Division of Pediatric EndocrinologyDivision of Pediatric EndocrinologyDivision of Pediatric EndocrinologyDivision of Pediatric EndocrinologyAdvancements in diabetes technology such as continuous glucose monitoring (CGM), insulin pumps, and automated insulin delivery provide opportunities to improve glycemic control for youth with type 1 diabetes (T1D). However, diabetes technology use is lower in youth on public insurance, and this technology use gap is widening in the US. There is a significant need to develop effective interventions and policies to promote equitable care. The dual purpose of this case series is as follows: (1) describe success stories of the CGM Time in Range Program (CGM TIPs), which removed barriers for initiating CGM and provided asynchronous remote glucose monitoring for youth on public insurance, and (2) advocate for improving CGM coverage by public insurance. We describe a series of six youths with T1D and public insurance who obtained and sustained use of CGM with assistance from the program. Three youths had improved engagement with the care team while on CGM and the remote monitoring protocol, and three youths were able to leverage sustained CGM wear to obtain insurance coverage for automated insulin delivery systems. CGM TIPs helped these youths achieve lower hemoglobin A1c and improved time in range (TIR). Despite the successes, expansion of CGM TIPs is limited by stringent barriers for CGM approval and difficult postapproval patient workflows to receive shipments. These cases highlight the potential for combining diabetes technology and asynchronous remote monitoring to support continued use and provide education to improve glycemic control for youth with T1D on public insurance and the need to reduce barriers for obtaining CGM coverage by public insurance.http://dx.doi.org/10.1155/2022/9911736
spellingShingle Ming Yeh Lee
Molly L. Tanenbaum
David M. Maahs
Priya Prahalad
Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action
Case Reports in Endocrinology
title Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action
title_full Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action
title_fullStr Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action
title_full_unstemmed Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action
title_short Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action
title_sort overcoming barriers to diabetes technology in youth with type 1 diabetes and public insurance cases and call to action
url http://dx.doi.org/10.1155/2022/9911736
work_keys_str_mv AT mingyehlee overcomingbarrierstodiabetestechnologyinyouthwithtype1diabetesandpublicinsurancecasesandcalltoaction
AT mollyltanenbaum overcomingbarrierstodiabetestechnologyinyouthwithtype1diabetesandpublicinsurancecasesandcalltoaction
AT davidmmaahs overcomingbarrierstodiabetestechnologyinyouthwithtype1diabetesandpublicinsurancecasesandcalltoaction
AT priyaprahalad overcomingbarrierstodiabetestechnologyinyouthwithtype1diabetesandpublicinsurancecasesandcalltoaction